Tag - vaccines

 
Menu
Search
 
April 19, 2025
 

Today's print edition

Home Delivery
Subscribe for more access

VACCINES

Japan Times
WORLD / Science & Health
Dec 3, 2020
Why the U.K. approved a COVID-19 vaccine first
Doses of the Pfizer-BioNTech vaccine will be injected starting next week, the government said.
Japan Times
ASIA PACIFIC
Dec 1, 2020
China gave COVID-19 vaccine candidate to North Korea's Kim, U.S. analyst says
China has provided North Korean leader Kim Jong Un and his family with an experimental coronavirus vaccine, a U.S. analyst said on Tuesday, citing two unidentified Japanese intelligence sources.
Japan Times
WORLD
Nov 30, 2020
Moderna to seek U.S. and EU clearance for COVID-19 vaccine
The move came after a new analysis showed the vaccine was highly effective in preventing COVID-19 with no serious safety problems.
Japan Times
COMMENTARY / World
Nov 30, 2020
Warp speed for clean energy? That won't work.
It might it be easier for the government to subsidize battery research, rather than pre-ordering particular battery units for later distribution? Maybe so, and it would be smart policy.
Japan Times
WORLD / FOCUS
Nov 30, 2020
Airlines face ‘mission of the century’ in shipping vaccines
Laid low by a COVID-19 outbreak that's decimated passenger demand, airlines will be the workhorses of the attempt to eradicate it, hauling billions of vials to every corner of the globe.
Japan Times
WORLD / Science & Health
Nov 29, 2020
U.K. poised to be first to approve Pfizer-BioNTech COVID-19 vaccine
The U.K. is poised to become the first country to approve Pfizer Inc. and BioNTech SE’s COVID-19 vaccine, ahead of a long line of countries waiting for protection from the coronavirus.
Japan Times
ASIA PACIFIC
Nov 27, 2020
COVID-19 vaccine delays undermine Indonesia’s path to immunity
With new cases topping 30,000 a week, Indonesia faces an urgent logistical challenge to ensure that vaccines are distributed across a country spanning thousands of kilometers.
Japan Times
ASIA PACIFIC
Nov 27, 2020
COVID-19 vaccine rush in China raises fears of booming black market
Chinese vaccine-makers have also yet to release any public data on the efficacy of their shots, making it difficult to tell how successful their efforts have been.
Japan Times
WORLD / Science & Health
Nov 27, 2020
AstraZeneca considers extra global vaccine trial as questions mount
Many low- and middle-income countries are relying on the firm, which has pledged to sell its vaccine at cost during the pandemic.
Japan Times
WORLD / Science & Health
Nov 26, 2020
After admitting error, AstraZeneca faces hard questions on vaccine
Scientists said a series of irregularities and omissions in the way AstraZeneca initially disclosed the data have eroded their confidence in the reliability of the results.
Japan Times
JAPAN / Science & Health
Nov 25, 2020
Not so fast, Japan experts say, as COVID-19 vaccines raise hopes
Medical experts say long-term safety and efficacy concerns remain as the vaccines are developed in record-setting time.
Japan Times
WORLD / Science & Health / FOCUS
Nov 24, 2020
Decades of work, and half a dose of fortune, drove Oxford vaccine success
The Oxford vaccinologists were exhilarated on Monday when drugmaker AstraZeneca, with whom they developed the shot, announced that it could be around 90% effective.
Japan Times
WORLD
Nov 23, 2020
U.S. plans first vaccinations in weeks, Operation Warp Speed chief says
Vaccinations against COVID-19 in the U.S. will "hopefully” start in less than three weeks, according to the head of the federal government’s program to accelerate a vaccine.
Japan Times
WORLD / Science & Health
Nov 21, 2020
Two companies say their vaccines are 95% effective. What does that mean?
You might assume that 95 out of every 100 people vaccinated will be protected from COVID-19. But that's not how the math works.
Japan Times
WORLD / Science & Health
Nov 19, 2020
Can first vaccines bring herd immunity? Experts have doubts.
Figuring out what's needed to achieve herd immunity with COVID-19 vaccines involves a range of factors, several of which are unknown.
Japan Times
WORLD / Science & Health
Nov 19, 2020
Pfizer-BioNTech coronavirus vaccine deliveries could start 'before Christmas'
Final trial results showed the vaccine had a 95% success rate and no serious side effects, the drugmakers said.
Japan Times
ASIA PACIFIC / Science & Health
Nov 18, 2020
China takes risk in rushing to use unproven coronavirus vaccines
China has made its unproven candidates widely available to demonstrate their safety and effectiveness to a country that has long been skeptical of vaccines.
Japan Times
ASIA PACIFIC / Science & Health
Nov 18, 2020
Sinovac's COVID-19 vaccine induces quick immune response, study finds
Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.
Japan Times
WORLD / Science & Health
Nov 18, 2020
Pfizer reaches safety milestone for COVID-19 vaccine, CEO says
Pfizer Inc. Chief Executive Officer Albert Bourla said that a key safety milestone had been reached in the study of its COVID-19 vaccine, and the drugmaker is now preparing to seek an emergency-use authorization from U.S. regulators.
In a first, Japan issues cease-and-desist order against Google
The Google logo is seen at the company's Bay View campus in Mountain View, California. Japanese authorities on Tuesday issued a cease-and-desist order to Google over an alleged violation of the country's anti-monopoly law.
Tokyo hotel operators face possible warnings over suspected price cartel
Foreign tourists gather on a platform at Kyoto Station on Wednesday.
Japan and the U.S. begin tariff talks on good terms, but without breakthroughs
Ryosei Akazawa, Japan's chief tariff negotiator, speaks to reporters in Washington on Wednesday.
Magnitude 5.0 earthquake jolts Nagano
A map showing the location of an earthquake that hit Nagano Prefecture on Friday evening, with the numbers indicating the seismic intensity on the shindo scale to 7.
Parts of Yamanote and Keihin-Tohoku lines to be suspended over weekend
Sections of the outer loop of Tokyo's Yamanote Line and the Keihin-Tohoku Line will be shut down all day Saturday, and from the start of service through around noon on Sunday.
Nothing sells like Shohei Ohtani, MLB’s marketing megastar
People walk past an advertisement featuring Los Angeles Dodgers two-way star Shohei Ohtani outside Tokyo Dome on March 18.
Tokyo stock picker advises Trump-proofing portfolios with Godzilla-creator Toho
The head of Godzilla, a Japanese monster movie character, is seen on a building of Toho Cinema in Tokyo. Toho is one tariff-defensive stock being recommended by brokers.
LDP and CDP lawmaker groups propose 0% consumption tax on food
A vegetable stand displays prices at a supermarket in Tokyo in 2023. Some lawmakers are proposing lowering the consumption tax on food to 0%, which is expected to result in a loss of up to ¥5 trillion in tax revenue annually.
Tokyo hotel operators face possible warnings over suspected price cartel
Foreign tourists gather on a platform at Kyoto Station on Wednesday.
Kyotographie 2025 opts for laughter and levity in the face of global strife
Palestinian American photographer Adam Rouhana’s exhibition at this year’s Kyotographie festival shows Palestinian life, not death and rubble.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Visitors walk past Sou Fujimoto's Grand Ring, which has been recognized as the largest wooden structure in the world.
Can a World Expo still matter? Japan is about to find out.
By Tomoko Otake

SUSTAINABLE JAPAN

BOARDING & INTERNATIONAL SCHOOL DAY 2025 (Sunday, April 20)
BOARDING & INTERNATIONAL SCHOOL DAY 2025 (Sunday, April 20)

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER